Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments EP News Bureau Mar 18, 2022 Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective 1st…
Biogen gets US FDA accelerated approval for Aduhelm to treat Alzheimer’s Lakshmipriya Nair Jun 8, 2021 It is the first new treatment approved for Alzheimer's since 2003 and is the first therapy that targets the fundamental…
